Concurrent Investment Advisors LLC Has $2.49 Million Holdings in MetLife, Inc. (NYSE:MET)

Concurrent Investment Advisors LLC increased its holdings in MetLife, Inc. (NYSE:MET) by 7.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,347 shares of the financial services provider’s stock after acquiring an additional 2,139 shares during the period. Concurrent Investment Advisors LLC’s holdings in MetLife were worth $2,485,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in MET. Swedbank AB raised its holdings in shares of MetLife by 5.3% in the 3rd quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock worth $162,499,000 after acquiring an additional 99,328 shares during the last quarter. Sequoia Financial Advisors LLC increased its stake in MetLife by 3.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 12,738 shares of the financial services provider’s stock valued at $1,051,000 after buying an additional 474 shares during the last quarter. Ballentine Partners LLC increased its stake in MetLife by 27.7% in the 3rd quarter. Ballentine Partners LLC now owns 9,579 shares of the financial services provider’s stock valued at $790,000 after buying an additional 2,076 shares during the last quarter. Lake Street Advisors Group LLC increased its stake in MetLife by 3.1% in the 3rd quarter. Lake Street Advisors Group LLC now owns 4,681 shares of the financial services provider’s stock valued at $386,000 after buying an additional 142 shares during the last quarter. Finally, CWC Advisors LLC. purchased a new stake in MetLife in the 3rd quarter valued at about $618,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Down 2.1 %

MET opened at $81.02 on Friday. The company has a 50 day moving average of $83.41 and a 200 day moving average of $81.35. The company has a market cap of $56.10 billion, a PE ratio of 13.57, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. MetLife, Inc. has a 12 month low of $67.30 and a 12 month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, sell-side analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is 36.52%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company increased their price objective on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday. TD Cowen increased their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Keefe, Bruyette & Woods decreased their price objective on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research note on Wednesday, February 12th. Finally, BMO Capital Markets began coverage on shares of MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target for the company. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $92.58.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.